Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with disease modifying therapies

被引：0
|
作者：
Barone, S. [1 ]
Palmieri, C. [2 ]
Gallelli, L. [3 ]
Rania, V. [3 ]
Bruno, P. A. [1 ]
Pasquale, M. [1 ]
Pascarella, A. [1 ]
Manzo, L. [1 ]
De Sarro, G. [3 ]
Gambardella, A. [1 ]
Valentino, P. [1 ]
机构：
[1] Magna Graecia Univ Catanzaro, Inst Neurol, Dept Med & Surg Sci, Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Clin Biochem & Cell Biol, Biochem Lab, Dept Expt & Clin Med, Catanzaro, Italy
[3] Magna Graecia Univ Catanzaro, Clin Pharmacol Unit, Dept Hlth Sci, Sch Med, Catanzaro, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1091
引用
收藏
页码：866 / 866
页数：1
相关论文
共 50 条
  • [21] Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies
    Ozakbas, Serkan
    Baba, Cavid
    Dogan, Yavuz
    Cevik, Sumeyye
    Ozcelik, Sinem
    Kaya, Ergi
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 58
  • [22] Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH
    Tortellini, Eeva
    Zingaropoli, Maria Antonella
    Mancarella, Giulia
    Marocco, Raffaella
    Carraro, Anna
    Jamhour, Meriem
    Barbato, Christian
    Guardiani, Mariasilvia
    Dominelli, Federica
    Pasculli, Patrizia
    Napoli, Anna
    Gaeta, Aurelia
    Mengoni, Fabio
    Zuccala, Paola
    Belvisi, Valeria
    Kertusha, Blerta
    Parente, Alberico
    Del Borgo, Cosmo
    Vullo, Vincenzo
    Ciardi, Maria Rosa
    Mastroianni, Claudio Maria
    Lichtner, Miriam
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [23] Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs
    Solchenberger, Hannah
    Odendahl, Marcus
    Schriefer, Dirk
    Proschmann, Undine
    al Rahbani, Georges Katoul
    Ziemssen, Tjalf
    Akguen, Katja
    PATHOGENS, 2025, 14 (03):
  • [24] Third dose of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
    Schiavetti, I.
    Sormani, M. P.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 104 - 105
  • [25] Adaptive B-cell and T-cell responses to SARS-CoV-2 vaccination in patients with Multiple Sclerosis on disease modifying immunotherapy
    Tomczak, A.
    Sumera, J.
    Joseph, Y.
    Wu, D.
    McDonald, J.
    Sattarnezhad, N.
    Kipp, L.
    Lock, C.
    Han, M. H.
    Dunn, J. E.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 76 - 76
  • [26] Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies
    Drulovic, Jelena
    Ivanovic, Jovana
    Martinovic, Vanja
    Tamas, Olivera
    Veselinovic, Nikola
    Cujic, Danica
    Gnjatovic, Marija
    Mesaros, Sarlota
    Pekmezovic, Tatjana
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 54
  • [27] Humoral response to SARS-CoV-2 natural Infection and mRNA vaccines among patients with multiple sclerosis
    Jaber, A.
    Greco, C.
    Sylvester, A.
    Tremblay, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 574 - 574
  • [28] Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis
    Hamzavi, Seyedeh Sadigheh
    Bahrololoom, Rosemina
    Saeb, Sepideh
    Marandi, Nahid Heydari
    Hosseini, Marzieh
    Abadi, Alimohammad Keshtvarz Hesam
    Jamalidoust, Marzieh
    BMC IMMUNOLOGY, 2024, 25 (01)
  • [29] Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies
    Sancho-Saldana, Agustin
    Gil Sanchez, Anna
    Quirant-Sanchez, Bibiana
    Nogueras, Lara
    Peralta, Silvia
    Solana, Maria Jose
    Gonzalez-Mingot, Cristina
    Gallego, Yhovanni
    Quibus, Laura
    Ramo-Tello, Cristina
    Presas-Rodriguez, Silvia
    Martinez-Caceres, Eva
    Torres, Pascual
    Hervas, Jose Vicente
    Valls, Joan
    Brieva, Luis
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (09)
  • [30] The Impact of SARS-CoV-2 Infection in Unvaccinated Multiple Sclerosis Patients on Disease-Modifying Therapies
    Al-Shammri, Suhail
    Chadha, Geeti
    Chattopadhyay, Arpita
    Doi, Suhail
    MEDICAL PRINCIPLES AND PRACTICE, 2023, 32 (02) : 143 - 148
12345